Investorideas.com breaking new for AI, drones, GPS and technology

Wednesday, May 26, 2021

#AI #Health #Stock News -GBT (OTC: $GTCH) introduces Generation II of its qTerm; #artificialintelligence

#AI #Health #Stock News -GBT (OTC: $GTCH) introduces Generation II of its qTerm; #artificialintelligence

 

qTerm’s second release includes body temperature, blood oxygen and heart rate vitals with higher stability, and consistency to cover wider spectrum of users measurement habits

 


San Diego, CA, May 26, 2021 -
(Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) via GBT Tokenize Corp, completed generation II of its qTerm device.  The GEN II release is a second version that includes a series of enhancements that target higher measurement accuracy, reliability and compatibility with a broader spectrum of users usage behavior. GBT's qTerm, a human vitals intelligent device is aimed to measure human vitals with a touch of a finger. Based on GEN I prototype testing, debugging and study, GBT’s concluded GEN II version to significantly advance the device’s general population compatibility. qTerm’s second release includes body temperature, blood oxygen and heart rate vitals with higher stability, and consistency to cover wider spectrum of users measurement habits. The device’s sensors were physically re-located to more efficient positions to enable best and consistent results.

An additional coprocessor chip was installed to provide an advanced adjusting algorithm to support broader user’s measuring habits, compensating for different inputs and providing consistent results. Similar to the GEN I version, the GEN II device will be accompanied by a smartphone app and synchronized web application to keep a history and provide analytics for user's records at a later phase. The web application will be providing a geographical location and proximity alert to assist with potential health risks. GEN II series of modifications are done as part of the Company’s preparations for an FDA certification to classify qTerm as a medical device to be marketed and sold in the US. The certification process will be also aimed to define the device for telemedicine purposes enabling remote vitals results to be sent to clinics and hospitals for physicians review in real time. qTerm’s GEN II device is currently under testing for technical performance and commercial look-and-feel features evaluation. 

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/05261Generation-II-qTerm.asp

 

"We are proud to announce the completion of our Gen II qTerm human vital device. We implemented a series of improvements in qTerm’s second release to achieve higher performance, accuracy, and user’s compatibility level. We put extra emphasis on the device ease of use, and user friendliness aspects. The device is currently under technical performance testing and commercial features look-and-feel evaluations. We strongly believe that qTerm can be an efficient, affordable health device in every household to assist with general health monitoring and early detection of symptoms and concerns. We are ever thriving to improve the device’s performance and capabilities, bringing it to the highest standards and regulations to enable people maintaining healthy life style." stated Danny Rittman, the Company’s Chief Technology Officer. 

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.


Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Monday, May 24, 2021

#AIEye #Podcast Episode 560: #Stocks discussed: (NYSE: $YEXT) (NasdaqGS: $KRBP) #artificialintelligence



 

 

 

#AIEye #Podcast Episode 560: #Stocks discussed: (NYSE: $YEXT) (NasdaqGS: $KRBP) #artificialintelligence

 

Yext Launches Support Answers, and Kiromic BioPharma Submits #AI-Derived IND Trial to FDA

 

Business Use of #AI Valued at $1.8T by 2027

 

Point Roberts WA, Vancouver BC – May 24, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/052421-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/05241YEXT-KRBP.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NYSE:YEXT) (NasdaqGS:KRBP)

 

AI search company Yext, Inc. (NYSE:YEXT) has announced the launch of Support Answers, “a suite of enterprise search solutions built for customer support teams.” This will employ modern, AI-powered solutions to provide answers to “a business's FAQs, product manuals, help articles, and more.” Marc Ferrentino, Chief Strategy Officer at Yext, said:

 

"Customers have consistently expressed their aversion to contacting customer support, but for the longest time, businesses have not had the technology powerful enough for them to resolve their issues independently. Today, that changes with the launch of Support Answers, which leverages our platform's multiple search algorithms to interpret people's intent and deliver contextually relevant, direct answers in a way that meets consumers' needs and expectations, and saves a business time and money."

 

Kiromic BioPharma, Inc. (NasdaqGS:KRBP) has submitted a novel Investigational New Drug (IND) to the U.S. Food and Drug Administration (FDA) for a Phase 1 clinical trial, derived from the company’s proprietary artificial intelligence neural network platform (Diamond AI), that “has the potential to be a universal CAR T-Cell therapy for any solid malignancy that expresses the biomarker Iso-mesothelin, with higher efficacy, higher safety, as well as lower manufacturing and distribution costs.” Maurizio Chiriva-Internati, CEO of Kiromic, explained:

 

Kiromic is in a unique position because its bioinformatic engine combines CancerDiff, a data-mining tool for the identification of tumor-preferred isoforms, with Diamond, an AI-driven immunogenic peptide identification system.

This combination allows Kiromic to identify targetable sections of a tumor isoform (peptides) that are a unique signature of cancer cells.

The advantage of Kiromic’s system is two-fold: 1) it saves time and money because it allows the prioritization of tumor-selective targets, and 2) it maximizes the likelihood of identifying targets that are safe by increasing the targeting specificity.

 

Business Use of AI Valued at $1.8T by 2027

 

A report published by Research and Markets analyzing the global Artificial General Intelligence market, finds that “the productivity gain potential for business use of AI represents approximately $1.8T in economic value by 2027.” A further excerpt from the report’s description indicates that this:

 

“…will be nine times more with the use of general-purpose AI solutions market as compared to today's silo AI approach. Productivity gains will be achieved by transactions conducted by AI autonomous agents or “bots”. It is estimated that more than 8% of the global economic activity in 2027 will be done autonomously by some kind of AI solution whereas this amounts to less than one percent today. This represents a dramatic rise in the use of AI for enterprise, industrial, and government automation.”

 

The report also projects variously that the embedded AI in building infrastructure and equipment will reach $18.1 globally by 2026, the general-purpose AI market will reach $4.25B globally by 2026 for enterprise apps and solutions, the global market for general-purpose AI support of big data and prescriptive analytics will reach $1.35B, and that over 35% of enterprise value will be directly or indirectly attributable to general-purpose AI solutions by 2027.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news,  third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories

Friday, May 21, 2021

#AIEye #Podcast 559: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $HPE); #artificialintelligence

 


#AIEye #Podcast 559: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $HPE); #artificialintelligence

 

GBT Launches PHASE I Testing for Infinia, and HPE Selected by Carestream Health for #AI #Healthcare Initiative

 

Global #Military #Robots Market to Reach $25.66B in 2027

 

Point Roberts WA, Vancouver BC – May 21, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence    featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/052121-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/05211GTCH-HPE.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

GBT Technologies Inc. (OTC PINK: GTCH) has announced the launch of PHASE I testing for its long range Infinia radio prototype system. The company’s CTO, Danny Rittman, explained:

 

"We started PHASE I of our Infinia long range radio system and we are pleased with our initial successful results. PHASE I’s target is to cover large metropolitan areas such as the city of Los Angeles. We are testing voice and data communication between all system's units with the focus on signal clarity, reliability and privacy. The Infinia system is working through sky waves and aimed for long distance audio and data communication. As with every radio system the main challenge is to maintain reliable communication at all times, seasons, and weather conditions, which is a crucial factor in case of emergencies. During our testing, we are evaluating each antenna's position, tuning, and landscape related effects. Our testing plan includes a few stages with the range being gradually increased. We are testing the device for viability with respect to sending health related information in parallel to voice communication over the audio channel. We are encouraged by our initial testing results and investing vast efforts into further assessments and experimentation to optimize best solutions.”

 

Carestream Health, a global provider of medical imaging systems, has selected Hewlett Packard Enterprise Company (NYSE:HPE) to power “a transformative new healthcare initiative based on artificial intelligence-as-a-service (AIaaS).” Carestream employs HPE GreenLake for Machine Learning Operations (ML Ops) to enhance “X-ray solutions and workflows for medical professionals and patients, facilitating the next generation of AI-enabled imaging devices for medical diagnosis.” Keith White, Senior Vice President and General Manager, HPE GreenLake Cloud Services, commented:

 

"Our partnership with Carestream, one of the worldwide leaders in the critical medical imaging space, closely aligns with HPE’s vision for innovation from edge-to-cloud, and provides cloud services to achieve outcome-driven digital transformations. It’s been so exciting working with Carestream to develop a scalable, next generation AI as a Service platform that enables their continued leadership in delivering improved patient outcomes and impactful insights to their customers."

 

Global Military Robots Market to Reach $25.66B in 2027

 

A report published by Fortune Business Insights finds that the global market for Military Robots will grow from $13.03 billion USD in 2020 to $25.66 billion in 2027 with a compound annual growth rate (CAGR) of 10.15 percent in the forecast period. The following excerpt from the report’s summary outlines driving factors in the market:

 

“Integration of technologies such as artificial intelligence, real-time data monitoring, and the Internet of Things (IoT) in military robots has drastically changed modern warfare dynamics. Soldiers’ uncertain threat could be easily identified and monitored through AI-integrated robots on air, ground, and sea platforms. These robots are used to track, record, and perform required counter-attacks on the targets located far away from the soldiers. This is also known as intelligence, surveillance, and reconnaissance (ISR) activity through robots.”

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure: GTCH is a paid featured ai stock on investorideas

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories